人巨细胞病毒感染及血清髓过氧化物酶水平与颈动脉粥样硬化的相关性分析
被引量：2
摘要
缺血性脑血管病的TOAST分型中动脉粥样硬化（atherosclerosis,AS）是重要的病因之一,而动脉-动脉栓塞也是以AS为基础的,因此积极探寻AS的病因及危险因素并开展针对性的防治是临床研究的重要环节。目前多项研究表明人巨细胞病毒（human cytomegalovirus,HCMV）的激活感染与AS的发生发展密切相关,而HCMV激活感染所引起的炎症和免疫反应受到越来越多的关注。
出处
《临床荟萃》
CAS
2013年第10期1139-1141,共3页
Clinical Focus
参考文献9
-
1The TH,van den berg AP,Harmsen MC,et al.The cytomegalovirus antigenmia assey:a plea for standardization[J].Scand J Infect Dis Suppl,1995,99:25-29.
-
2Roger KS,Leonard PV,Tom T,et al.Myeloperoxidase:a useful biomarker for cardiovascular disease risk stratification?[J].Clin Chem,2009,55(8):1462-1470.
-
3Salonen I,Huttunen K,Hirvonen MR,et al.Serum myeloperoxidase is independent of the risk factors of atherosclerosis[J].Coro Art Dise,2012,23(4):251-258.
-
4Marcin S,Grazyna S,Marek K,et al.Diagnostic efficacy of myeloperoxidase for the detection of acute coronary syndromes[J].Eur J Clin Invest,2011,41(6):667-671.
-
5AI-Ghamdi A.Role of herpes simplex virus-1,cytomegalovirus and Epstein-Barr virus in atherosclerosis[J].Pak J Pharm Sci,2012,25(1):89-97.
-
6Tremolada S,Delbue S,Ferraresso M,et al.Search for genomic sequences of microbial agents in atherosclerotic plaques[J].Int J Immuo Phathol Pharmacol,2011,24(1):243-246.
-
7Imbronito AV,Marcelino SL,Grande SR,et al.Detection of human cytomegalovirus and Epstein-Barr virus in coronary atherosclerotic tissue[J].Braz J Microbiol,2010,42(10):1590-1597.
-
8Zelzer S,Stiegler P,Kapitan M,et al.Myeloperoxidase as serum marker for detection of CMV infections and rejections in patients after liver and heart transplantation[J].Transpl Immunol,2009,20(3):121-126.
-
9Koestenbauer S,Stiegler P,Stadlbauer V,et al.Myeloperoxidase and carbonyl proteins:promising markers for non-invasive monitoring of graft rejection after heart transplantation[J].J Heart Lung Transplant,2010,29(12):1352-1357.
同被引文献29
-
1Buffon A, Biasucci LM, Liuzzo G, et al. Widespread coronary inflammation in unstable angina [Jl. N Engl J Med, 2002, 347 (1): 5-12.
-
2Libby P, Theroux P. Pathophysiology of coro- nary artery disease [ J ]. Circulation, 2005, 111 (25): 3481 -3488.
-
3Shao B, Pennathur S, Heinecke JW. My- eloperoxidase targets apolipoprotein A -I, the major high density lipoprotein protein, for site -specific oxidation in human atheroselerotie lesions [ J ]. J Biol Chem, 2012, 287 (9): 6375 -6386.
-
4Cook NL, Viola HM, Sharov VS, et al. My- eloperoxidase- derived oxidants inhibit sareo/ endoplasmie retieulum Ca2 + - ATPase activity and perturb Ca2 + homeostasis in human coro- nary artery endothelial cells [ J ]. Free Radie BiolMed, 2012, 52 (5): 951-961.
-
5Chen LQ, Rohatgi A, Ayers CR, et al. Race - specific associations of myeloperoxi- dase with atheroselerosis in a population - based sample: the Dallas Heart Study [ Jl. Atheroselerosis, 2011, 219 ( 2 ) : 833 - 838.
-
6Chen L, Ling YS, Lin CH, et al. Combined use of heparin and anisodamine reduces the risk of early thrombosis in native arteriovenous fistu- la [J]. Vascular, 2013. [Epub ahead of print ].
-
7Powell AK, Yates EA, Fernig DG, et al. Interactions of heparin/heparan sulfate withproteins: appraisal of structural factors and experimental approaches [ J ]. Glycobiology, 2004, 14 (4): 17R-30R.
-
8Zheng L, Nukuna B, Brennan ML, et al. Apollpoprotein A - I is a selective target for myeloperoxidase - catalyzed oxidation and functional impairment in subjects with cardio- vascular disease [ J]. J Clin Invest, 2004, 114 (4): 529-541.
-
9Bergt C, Pennathur S, Fu X, et al. The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1 - dependent cholesterol transport [ J ]. Proc Natl Acad Sci USA, 2004, 101 (35): 13032-13037.
-
10Podrez EA, Febbraio M, Sheibani N, et al. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte -generated reactive nitrogen species [ J ]. J Clin Invest, 2000, 105 (8): 1095 - 1108.
-
1肖雷,袁锦楣,郝洪军,唐建,贾战斗,刘向志.格林-巴利综合征与人巨细胞病毒感染关系的初步研究[J].临床神经科学,1994,2(4):223-224.
-
2高连生,郝树森,陈稚丽,马娟春,张丽英,李军,常宁,倪志超,高乐.缺血性脑血管病患者溶血磷脂酸与人巨细胞病毒感染的相关性[J].临床荟萃,2012,27(9):777-778. 被引量：3
-
3章立,金友雨,蔡海波,周海金,臧秋玲,王洒.人巨细胞病毒感染与急性缺血性脑卒中的关系[J].中华全科医学,2014,12(1):63-64. 被引量：2
-
4李莉娟.探讨人巨细胞病毒感染在进展性动脉硬化性脑梗死患者病情发展的作用[J].中国实用神经疾病杂志,2016,19(24):111-112.
-
5王慧,何俊瑛,高玉林,孔伟丽.膦甲酸钠对动脉粥样硬化缺血性脑血管病巨细胞病毒激活状态干预及临床疗效对比分析应用[J].脑与神经疾病杂志,2008,16(2):137-139. 被引量：1
-
6巩忠,何俊瑛,高玉林.巨细胞病毒感染与动脉粥样硬化及脑梗死的相关性研究进展[J].国外医学（老年医学分册）,2005,26(1):20-24. 被引量：1
-
7匡桂芳,蒋玉红,贺莉娜,邓萍.巨细胞病毒感染在抽动障碍中的临床意义初探[J].中国心理卫生杂志,2001,15(3):201-202. 被引量：6
-
8李秀江,刘力,高润发.动脉—动脉栓塞性脑梗死500例临床观察[J].山东医药,2006,46(13):72-72.
-
9王桂斌,蒋立,史艳萍,刘运海.HCMV感染与动脉粥样硬化及动脉硬化性缺血性脑血管病相关性研究进展[J].国际神经病学神经外科学杂志,2008,35(1):58-62. 被引量：7
-
10焉鹏,陈双峰,梁爱军,马宁.人巨细胞病毒感染与溃疡性结肠炎关系的研究[J].山东医药,2005,45(22):36-37. 被引量：1
